» Articles » PMID: 26323654

High-Attenuation Mucus Impaction in Patients With Allergic Bronchopulmonary Aspergillosis: Objective Criteria on High-Resolution Computed Tomography and Correlation With Serologic Parameters

Overview
Specialty Radiology
Date 2015 Sep 2
PMID 26323654
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the study was to correlate the high-resolution computed tomography (HRCT) finding of high-attenuation mucus (HAM) impaction, including mean CT density and immunologic parameters in patients with allergic bronchopulmonary aspergillosis (ABPA). The institutional review board approved the study, and informed written consent was obtained. A total of 100 consecutive patients diagnosed with ABPA between June 2012 and December 2013 undergoing HRCT were enrolled. HRCT scan of the chest was evaluated for central bronchiectasis, mucoid impaction, and number of involved bronchial segments. Findings of mucoid impaction in patients were classified as HAM and non-HAM. CT attenuation values and mean CT density were calculated. Serologic parameters were assessed for total immunoglobin E (IgE), specific IgE, and absolute eosinophil count. Patients with HAM impaction on HRCT were found to have significantly higher levels of total IgE (P < 0.001), specific IgE (P = 0.03), and number of bronchial segments affected (P < 0.001). We found a CT density value of 70 Hounsfield units (HU) as an adequate cutoff value for HAM impaction. CT density >100HU is correlated with significantly higher values of serologic parameters. The present study suggests a relation between absolute HU values of HAM impaction and absolute value of serologic parameters in ABPA.

Citing Articles

Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.

Agarwal R, Sehgal I, Muthu V, Denning D, Chakrabarti A, Soundappan K Eur Respir J. 2024; 63(4).

PMID: 38423624 PMC: 10991853. DOI: 10.1183/13993003.00061-2024.


Management of comorbidities in difficult and severe asthma.

Khan J, Moran B, McCarthy C, Butler M, Franciosi A Breathe (Sheff). 2023; 19(3):230133.

PMID: 38020342 PMC: 10644109. DOI: 10.1183/20734735.0133-2023.


Lung cancer resembling allergic bronchopulmonary mycosis with an asthma-like presentation.

Kai Y, Kataoka R, Suzuki K, Takano M, Muro S Respir Med Case Rep. 2023; 45:101887.

PMID: 37435548 PMC: 10331302. DOI: 10.1016/j.rmcr.2023.101887.


Allergic Bronchopulmonary Mycosis Complicated with Lung Adenocarcinoma.

Ohnishi H, Tsuji K, Iguchi M, Oyama K, Yokoyama A Intern Med. 2022; 61(23):3563-3568.

PMID: 36450453 PMC: 9790769. DOI: 10.2169/internalmedicine.9437-22.


Value of CT Radiomics Combined with Clinical Features in the Diagnosis of Allergic Bronchopulmonary Aspergillosis.

Qian X, Rong H, Wei X, Rong G, Yao M Comput Math Methods Med. 2022; 2022:5317509.

PMID: 35572830 PMC: 9098310. DOI: 10.1155/2022/5317509.